Real-world assessment of diquafosol in dry eye patients with risk factors such as contact lens, meibomian gland dysfunction, and conjunctivochalasis: subgroup analysis from a prospective observational study
Masahiko Yamaguchi,1 Takeshi Nishijima,2 Jun Shimazaki,3 Etsuko Takamura,4 Norihiko Yokoi,5 Hitoshi Watanabe,6 Yuichi Ohashi1 1Department of Ophthalmology, Ehime University School of Medicine, Ehime, 2Department of Safety Vigilance Group, Santen Pharmaceutical Co., Ltd., Osaka, 3Department of Ophth...
Guardado en:
Autores principales: | Yamaguchi M, Nishijima T, Shimazaki J, Takamura E, Yokoi N, Watanabe H, Ohashi Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f61c014d2cc4446fbf1e2a040096416c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction
por: Amano S, et al.
Publicado: (2017) -
Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study
por: Shima Fukuoka, et al.
Publicado: (2019) -
Emerging treatment options for meibomian gland dysfunction
por: Qiao J, et al.
Publicado: (2013) -
Visible Meibomian Gland Structure Increases After Vectored Thermal Pulsation Treatment in Dry Eye Disease Patients with Meibomian Gland Dysfunction
por: Hura AS, et al.
Publicado: (2020) -
Influence of eyelid pigmentation on the diagnosis of meibomian gland dysfunction
por: Blumberg MJ, et al.
Publicado: (2019)